[Chromosomal in study patients treated with anticonvulsant drugs]. 1977

L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo

Selected at random from a special consultation in a general teaching hospital in the City of La Habana, 10 epileptic patients were studied. They were clinically, as well as electroencephalographically diagnosed; followed by treatment with different anticonvulsant drugs for a period not less than 3 months and not greater than 5 years. 100 metaphases of each one of the patients were analyzed without finding any deviation in the normal diploidy number of chromosomes (2n = 46), nor alterations in the morphology of the same. We consider this work a preliminary report which does not permit us to arrive at definite conclusions at this moment; but in subsequent work, which we are already carrying out, we hope to issue some considerations with respect to the use of anticonvulsant drugs and their effects in the human chromosomes.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002877 Chromosomes, Human Very long DNA molecules and associated proteins, HISTONES, and non-histone chromosomal proteins (CHROMOSOMAL PROTEINS, NON-HISTONE). Normally 46 chromosomes, including two sex chromosomes are found in the nucleus of human cells. They carry the hereditary information of the individual. Chromosome, Human,Human Chromosome,Human Chromosomes
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
January 1973, Acta neurologica latinoamericana,
L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
May 1989, Anales de medicina interna (Madrid, Spain : 1984),
L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
January 1972, Humangenetik,
L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
September 2001, European journal of clinical investigation,
L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
May 1984, Medicina clinica,
L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
February 1984, Journal of the American Veterinary Medical Association,
L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
September 2004, Journal of clinical pharmacology,
L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
November 2004, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
January 2001, Clinica chimica acta; international journal of clinical chemistry,
L Rodríguez Rivera, and R Flores García, and C Gutiérrez Calzado, and A Betancourt Rovira, and A Sánchez Castillo
January 1970, Acta dermato-venereologica,
Copied contents to your clipboard!